The convergence of Artificial Intelligence (AI), photonics, and molecular modeling represents a groundbreaking evolution in computational biomedicine. Traditional electronic-based computation faces physical and temporal limitations when simulating the dynamic complexity of biomolecular systems. To overcome these constraints, this work introduces an integrated framework in which light-driven photonic simulations and AI-guided molecular modeling interact in real time to accelerate precision drug discovery. In this hybrid architecture, photons act as ultra-fast computational carriers capable of encoding molecular interactions through optical interference and energy field modulation, while AI algorithms interpret the resulting photonic patterns to predict molecular binding, stability, and reactivity. This synergistic loop—where light simulates and intelligence optimizes—creates a continuously adaptive computational environment for exploring vast chemical and biological spaces. The proposed approach demonstrates that photon-assisted molecular modeling can compute energy landscapes, conformational transitions, and ligand–protein affinities at speeds previously unattainable by classical simulation. In parallel, deep neural networks enhance precision by refining structural predictions and therapeutic specificity. Together, AI and photonics lay the foundation for a new paradigm of intelligent, light-powered computation in medicine, enabling real-time, individualized, and adaptive therapeutic design. This fusion redefines not only the speed of discovery but also the philosophy of precision medicine—transforming light itself into an instrument of molecular intelligence.